Who profits from fast-track drug approvals: patients or industry?
Paul Kubler, from Royal Brisbane and Women’s Hospital, offers a balanced analysis of the benefits and potential dangers of allowing early access to new therapies.
Colic: which treatments work and which don’t?
Valerie Sung, a paediatrician at the Royal Children’s Hospital in Melbourne and research fellow at the Murdoch Children’s Research Institute, discusses the latest thinking on colic. Is it always related to intestinal issues and how can it be managed?
Combining anticoagulants and antiplatelet drugs in coronary artery disease
Health professionals may consider combining anticoagulation and antiplatelet drugs in patients with coronary artery disease, to prevent further cardiovascular events. This article details approaches for patients with stable coronary disease or acute coronary syndrome.
Other articles in the August issue of Australian Prescriber include: ---
Travelling with medicines in 2018
Brief interventions for alcohol and other drug use
Medicinal mishap: Communication and ciprofloxacin-associated acute kidney disease
New drugs: atezolizumab for non-small cell lung cancer, guanfacine hydrochloride for attention deficit hyperactivity disorder, ocrelizumab for multiple sclerosis, palbociclib for breast cancer, silodosin for benign prostatic hypertrophy
